Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Cavalu

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 27, 2022
Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needsSameh Saber, Mohamed Nasr, Mohamed M Y Kaddah, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 10, 2022
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitisSimona Cavalu, Hossam Sharaf, Sameh Saber, et al.
Life Sciences|June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenibAlexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitisMohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Frontiers in Pharmacology|June 27, 2022
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative ColitisAmir Mohamed Abdelhamid, Mahmoud E Youssef, Simona Cavalu, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 27, 2022
Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needsSameh Saber, Mohamed Nasr, Mohamed M Y Kaddah, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 10, 2022
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitisSimona Cavalu, Hossam Sharaf, Sameh Saber, et al.
Life Sciences|June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenibAlexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitisMohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Frontiers in Pharmacology|June 27, 2022
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative ColitisAmir Mohamed Abdelhamid, Mahmoud E Youssef, Simona Cavalu, et al.
Pageof 13